RxDoctor Payments Data

Lauro Arteaga

Physician Assistant · Los Angeles, CANPI 1083625081

Payments from drug & device makers

$623in general payments, 2019–2025

Across 30 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$183
  • Novo Nordisk$118
  • Corcept Therapeutics$108
  • Lilly USA, LLC$47
  • Amgen$43
  • Abbott$30
  • plus $94 from 5 others

What the payments were for

  • Food & beverage$623100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$623 in reported general payments places this provider in the 65th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$6,330
Medicare patients
36
Services billed
197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate56$52,607
EliquisApixaban44$30,681
JardianceEmpagliflozin20$20,771
FarxigaDapagliflozin Propanediol21$17,192
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog28$7,726
Diclofenac Sodium45$3,192
Atorvastatin Calcium281$3,171
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,463
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,127
Metformin Hcl219$1,987
Losartan Potassium137$1,720
Albuterol Sulfate HfaAlbuterol Sulfate47$1,493
Tamsulosin Hcl84$1,396
Omeprazole112$1,386
Lisinopril124$1,258

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$17$30,68144 claims
AstraZenecaFarxiga$183$17,19221 claims
GSKShingrix$13$2,46312 claims
Lilly USA, LLCHumulin N$47$1,16714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →